Cocrystal development is an increasingly popular step in the drug development process. By forming cocrystals – crystalline complexes formed by two (or more) separate molecular entities – drug developers can modify the physical properties of an API while preserving the benefits of a crystalline solid form.

  • Unique API intellectual property protection
  • Increased formulation stability
  • Enhanced physiochemical properties

Veranova is your next great decision

Discover new ways to advance your science with Veranova.

Contact us